litlas
Log inCreate account

Ben Ho Park

Active 2000–2026

Also published as
Ben-Ho Park
87
Papers
19,846
Citations
59
h-index
85
i10-index

Citations

Citations per year for Ben Ho Park1974: 1 citations1981: 1 citations1993: 1 citations1995: 1 citations1996: 1 citations1997: 1 citations1999: 1 citations2000: 3 citations2001: 23 citations2002: 56 citations2003: 92 citations2004: 105 citations2005: 128 citations2006: 110 citations2007: 208 citations2008: 277 citations2009: 317 citations2010: 311 citations2011: 318 citations2012: 275 citations2013: 260 citations2014: 290 citations2015: 233 citations2016: 221 citations2017: 200 citations2018: 177 citations2019: 578 citations2020: 572 citations2021: 601 citations2022: 505 citations2023: 425 citations2024: 666 citations2025: 316 citations2026: 9 citations1975–1980: no citations, so these years are not shown1982–1992: no citations, so these years are not shown1994: no citations, so this year is not shown1998: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,543 citing papers, 33.9% of this breakdownChina: 941 citing papers, 9% of this breakdownUnited Kingdom: 664 citing papers, 6.4% of this breakdownItaly: 493 citing papers, 4.7% of this breakdownGermany: 467 citing papers, 4.5% of this breakdownCanada: 372 citing papers, 3.6% of this breakdownSpain: 324 citing papers, 3.1% of this breakdownFrance: 319 citing papers, 3.1% of this breakdownJapan: 317 citing papers, 3% of this breakdownAustralia: 260 citing papers, 2.5% of this breakdownNetherlands: 232 citing papers, 2.2% of this breakdownSouth Korea: 186 citing papers, 1.8% of this breakdown
0%33.9%Other 22.2%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology60.6%
  • Medicine33.2%
  • Immunology and Microbiology1.9%
  • Neuroscience1.1%
  • Computer Science1%
  • Chemistry0.5%
  • Other1.7%

Topics

  • Cancer Genomics and Diagnostics7.5%
  • Epigenetics and DNA Methylation5.6%
  • RNA modifications and cancer2.6%
  • Cancer Cells and Metastasis2.5%
  • Cancer-related gene regulation2.4%
  • PI3K/AKT/mTOR signaling in cancer2.1%
  • Other77.3%

Coauthors

All papers

Open in search
  1. AACR Project GENIE: Powering Precision Medicine through an International Consortium

    Authors: Fabrice André, Mónica Arnedos, Alexander S. Baras, José Baselga, Philippe L. Bédard, Michael F. Berger, Mariska Bierkens, Fabien Calvo, Ethan Cerami, Debyani Chakravarty, Kristen K. Dang, Nancy E. Davidson, Catherine Del Vecchio Fitz, Semih Doğan, Raymond N. DuBois, Matthew D. Ducar, P. Andrew Futreal, Jianjiong Gao, Francisco Moacir Pinheiro Garcia, Stuart M. Gardos, Christopher D. Gocke, Benjamin Groß, Justin Guinney, Zachary Heins, Stephanie Hintzen, Hugo M. Horlings, Jan Hudeček, David M. Hyman, Suzanne Kamel‐Reid, Cyriac Kandoth, Walter Kinyua, Priti Kumari, Ritika Kundra, Marc Ladanyi, Céline Lefèbvre, Michele L. Lenoue-Newton, Eva M. Lepisto, Mia Levy, Neal I. Lindeman, James Lindsay, David Liu, Zhibin Lu, Laura E. MacConaill, Ian Maurer, David S. Maxwell, Gerrit A. Meijer, Funda Meric‐Bernstam, Christine Micheel, Clinton Miller, Gordon B. Mills, Nathanael D. Moore, Petra M. Nederlof, Larsson Omberg, John A. Orechia, Ben Ho Park, Trevor J. Pugh, Brendan Reardon, Barrett J. Rollins, Mark J. Routbort, Charles L. Sawyers, Deborah Schrag, Nikolaus Schultz, Kenna Shaw, Priyanka Shivdasani, Lillian L. Siu, David B. Solit, Gabe S. Sonke, Jean Charles Soria, Parin Sripakdeevong, Natalie Stickle, Thomas Stricker, Shawn M. Sweeney, Barry S. Taylor, Jelle J. ten Hoeve, Stacy B. Thomas, Eliezer M. Van Allen, Laura van ‘t Veer, Tony van de Velde, Harm van Tinteren, Victor E. Velculescu, Carl Virtanen, Emile E. Voest, Lucy Lu Wang, Chetna Wathoo, Stuart Watt, Celeste Yu, Thomas Yu, Emily Yu, Ahmet Zehir, Hongxin Zhang - Cancer Discovery 2017 cited by 2,004

  2. Circulating tumor DNA: current challenges for clinical utility

    Authors: Donna K. Dang, Ben Ho Park - Journal of Clinical Investigation 2022 cited by 205

  3. The Consensus Coding Sequences of Human Breast and Colorectal Cancers

    Authors: Tobias Sjöblom, Siân Jones, Laura D. Wood, D. Williams Parsons, Jimmy Lin, Thomas D. Barber, Diana Mandelker, Rebecca Leary, Janine Ptak, Natalie Silliman, Steve Szabo, Phillip Buckhaults, Christopher Farrell, Paul F. Meeh, Sanford D. Markowitz, Joseph Willis, Dawn Dawson, James K. V. Willson, Adi F. Gazdar, James Hartigan, Leo Wu, Changsheng Liu, Giovanni Parmigiani, Ben Ho Park, Kurtis E. Bachman, Nickolas Papadopoulos, Bert Vogelstein, Kenneth W. Kinzler, Victor E. Velculescu - Science 2006 cited by 3,183

  4. Single cell analysis of cribriform prostate cancer reveals cell intrinsic and tumor microenvironmental pathways of aggressive disease

    Authors: Hong Yuen Wong, Quanhu Sheng, Amanda B. Hesterberg, Sarah Croessmann, Brenda Rios, Khem Raj Giri, Jorgen Jackson, Adam X. Miranda, Evan Watkins, Kerry Schaffer, Meredith Donahue, Elizabeth Winkler, David F. Penson, Joseph A. Smith, S. Duke Herrell, Amy N. Luckenbaugh, Daniel A. Barocas, Young J. Kim, Diana Graves, Giovanna A. Giannico, Jeffrey C. Rathmell, Ben Ho Park, Jennifer Gordetsky, Paula J. Hurley - Nature Communications 2022 cited by 124

  5. Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis

    Authors: Susana García‐Recio, Toshinori Hinoue, Gregory Wheeler, Benjamin Kelly, Ana C. Garrido-Castro, Tomás Pascual, Aguirre A. de Cubas, Youli Xia, Brooke Felsheim, Marni B. McClure, Andrei Rajkovic, Ezgi Karaesmen, Markia A. Smith, Cheng Fan, Paula I. González-Ericsson, Melinda E. Sanders, Chad J. Creighton, Jay Bowen, Kristen Leraas, Robyn Burns, Sara E. Coppens, Amy Wheless, Salma Rezk, Amy Garrett, Joel S. Parker, Kelly K. Foy, Hui Shen, Ben Ho Park, Ian E. Krop, Carey K. Anders, Julie M. Gastier‐Foster, Mothaffar F. Rimawi, Rita Nanda, Nancy U. Lin, Claudine Isaacs, P. Kelly Marcom, Anna Maria Storniolo, Fergus J. Couch, Uma Chandran, Michael A. Davis, Jonathan C. Silverstein, Alexander J. Ropelewski, Minetta C. Liu, Susan G. Hilsenbeck, Larry Norton, Andrea L. Richardson, W. Fraser Symmans, Antonio C. Wolff, Nancy E. Davidson, Lisa A. Carey, Adrian V. Lee, Justin M. Balko, Katherine A. Hoadley, Peter W. Laird, Elaine R. Mardis, Tari A. King, AURORA US Network, Aguirre A. de Cubas, Charles M. Perou - Nature Cancer 2022 cited by 114

  6. Biomarkers for Systemic Therapy in Metastatic Breast Cancer: ASCO Guideline Update

    Authors: N. Lynn Henry, Mark R. Somerfield, Zoneddy Dayao, Anthony Elias, Kevin Kalinsky, Lisa M. McShane, Beverly Moy, Ben Ho Park, Kelly M. Shanahan, Priyanka Sharma, Rebecca Shatsky, Erica Stringer-Reasor, Melinda L. Telli, Nicholas C. Turner, Angela DeMichele - Journal of Clinical Oncology 2022 cited by 129

  7. The Genomic Landscapes of Human Breast and Colorectal Cancers

    Authors: Laura D. Wood, D. Williams Parsons, Siân Jones, Jimmy Lin, Tobias Sjöblom, Rebecca Leary, Dong Shen, Simina M. Boca, Thomas D. Barber, Janine Ptak, Natalie Silliman, Steve Szabo, Zoltán Dezső, Vadim Ustyanksky, Tatiana Nikolskaya, Yuri Nikolsky, Rachel Karchin, Paul A. Wilson, Joshua S. Kaminker, Zemin Zhang, Randal Croshaw, Joseph Willis, Dawn Dawson, Michail Shipitsin, James K. V. Willson, Saraswati Sukumar, Kornélia Polyák, Ben Ho Park, Charit L. Pethiyagoda, P.V. Krishna Pant, Dennis G. Ballinger, Andrew B. Sparks, James Hartigan, Douglas R. Smith, Erick Suh, Nickolas Papadopoulos, Phillip Buckhaults, Sanford D. Markowitz, Giovanni Parmigiani, Kenneth W. Kinzler, Victor E. Velculescu, Bert Vogelstein - Science 2007 cited by 2,855

  8. NSD2 Links Dimethylation of Histone H3 at Lysine 36 to Oncogenic Programming

    Authors: Alex Kuo, Peggie Cheung, Kaifu Chen, Barry M. Zee, Mitomu Kioi, Josh Lauring, Yuanxin Xi, Ben Ho Park, Xiaobing Shi, Benjamin A. García, Wei Li, Or Gozani - Molecular Cell 2011 cited by 442

  9. Activation of the IFN Signaling Pathway is Associated with Resistance to CDK4/6 Inhibitors and Immune Checkpoint Activation in ER-Positive Breast Cancer

    Authors: Carmine De Angelis, Xiaoyong Fu, Maria Letizia Cataldo, Agostina Nardone, Resel Pereira, Jamunarani Veeraraghavan, Sarmistha Nanda, Lanfang Qin, Vidyalakshmi Sethunath, Tao Wang, Susan G. Hilsenbeck, Matteo Benelli, Ilenia Migliaccio, Cristina Guarducci, Luca Malorni, Lacey M. Litchfield, Jiangang Liu, Joshua Donaldson, Pier Selenica, David N. Brown, Britta Weigelt, Jorge S. Reis‐Filho, Ben Ho Park, Sara A. Hurvitz, Dennis J. Slamon, Mothaffar F. Rimawi, Valerie M. Jansen, Rinath Jeselsohn, C. Kent Osborne, Rachel Schiff - Clinical Cancer Research 2021 cited by 94

  10. DNMT1 and DNMT3b cooperate to silence genes in human cancer cells

    Authors: Ina Rhee, Kurtis E. Bachman, Ben Ho Park, Kam-Wing Jair, Ray-Whay Chiu Yen, Kornel E. Schuebel, Hengmi Cui, Andrew P. Feinberg, Christoph Lengauer, Kenneth W. Kinzler, Stephen B. Baylin, Bert Vogelstein - Nature 2002 cited by 1,250

  11. Monitoring Daily Dynamics of Early Tumor Response to Targeted Therapy by Detecting Circulating Tumor DNA in Urine

    Authors: Hatim Husain, Vladislava O. Melnikova, Karena Kosco, Brian Woodward, Soham More, Sandeep C. Pingle, Elizabeth Weihe, Ben Ho Park, Muneesh Tewari, Mark G. Erlander, Ezra E.W. Cohen, Scott M. Lippman, Razelle Kurzrock - Clinical Cancer Research 2017 cited by 131

  12. Oncogenic signals prime cancer cells for toxic cell overgrowth during a G1 cell cycle arrest

    Authors: Reece Foy, Lisa Crozier, Aanchal Udaynath Pareri, Juan Manuel Valverde, Ben Ho Park, Tony Ly, Adrian T. Saurin - Molecular Cell 2023 cited by 67

  13. p21 and p27: roles in carcinogenesis and drug resistance

    Authors: Abde M. Abukhdeir, Ben Ho Park - Expert Reviews in Molecular Medicine 2008 cited by 471

  14. Endocrine and Targeted Therapy for Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer—Capivasertib-Fulvestrant: ASCO Rapid Recommendation Update

    Authors: Harold J. Burstein, Angela DeMichele, Lesley Fallowfield, Mark R. Somerfield, N. Lynn Henry, for the Biomarker Testing and Endocrine and Targeted Therapy in Metastatic Breast Cancer Expert Panels, N. Lynn Henry, Zoneddy Dayao, Anthony Elias, Kevin Kalinsky, Lisa M. McShane, Beverly Moy, Ben Ho Park, Kelly M. Shanahan, Priyanka Sharma, Rebecca Shatsky, Erica Stringer-Reasor, Melinda L. Telli, Nicholas C. Turner, Angela DeMichele, Harold J. Burstein, Debra L. Barton, Ali Dorris, Lesley Fallowfield, Dharamvir Jain, Stephen Johnston, Larissa A. Korde, Jennifer K. Litton, Erin Macrae, Lindsay L. Peterson, Praveen Vikas, Rachel L. Yung, Hope S. Rugo - Journal of Clinical Oncology 2024 cited by 48

  15. CHIP Happens: Clonal Hematopoiesis of Indeterminate Potential and Its Relationship to Solid Tumors

    Authors: Sarah C. Reed, Sarah Croessmann, Ben Ho Park - Clinical Cancer Research 2022 cited by 85

  16. Hotspot ESR1 Mutations Are Multimodal and Contextual Modulators of Breast Cancer Metastasis

    Authors: Zheqi Li, Yang Wu, Megan E. Yates, Nilgun Tasdemir, Amir Bahreini, Jian Chen, Kevin M. Levine, Nolan Priedigkeit, Azadeh Nasrazadani, Simak Ali, Laki Buluwela, Spencer Arnesen, Jason Gertz, Jennifer K. Richer, Benjamin Troness, Dorraya El‐Ashry, Qiang Zhang, Lorenzo Gerratana, Youbin Zhang, Massimo Cristofanilli, Maritza A. Montanez, Prithu Sundd, Callen T. Wallace, Simon C. Watkins, Caterina Fumagalli, Elena Guerini‐Rocco, Li Zhu, George C. Tseng, Nikhil Wagle, Jason S. Carroll, Paul Jank, Carsten Denkert, Maria Margarete Karsten, Jens‐Uwe Blohmer, Ben Ho Park, Peter C. Lucas, Jennifer M. Atkinson, Adrian V. Lee, Steffi Oesterreich - Cancer Research 2022 cited by 85

  17. Detection of Cancer DNA in Plasma of Patients with Early-Stage Breast Cancer

    Authors: Julia A. Beaver, Danijela Jelovac, Balukrishna Sasidharan, Rory L. Cochran, Sarah Croessmann, Daniel J. Zabransky, Hong Yuen Wong, Patricia Valda Toro, Justin Cidado, Brian Blair, David Chu, Timothy F. Burns, Michaela J. Higgins, Vered Stearns, Lisa K. Jacobs, Mehran Habibi, Julie R. Lange, Paula J. Hurley, Josh Lauring, Dustin A. VanDenBerg, Jill Kessler, Stacie C. Jeter, Michael L. Samuels, Dianna Maar, Leslie Cope, Ashley Cimino‐Mathews, Pedram Argani, Antonio C. Wolff, Ben Ho Park - Clinical Cancer Research 2014 cited by 396

  18. Randomized Phase III Postoperative Trial of Platinum-Based Chemotherapy Versus Capecitabine in Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy: ECOG-ACRIN EA1131

    Authors: Ingrid A. Mayer, Fengmin Zhao, Carlos L. Arteaga, W. Fraser Symmans, Ben Ho Park, Brian L. Burnette, Amyé Tevaarwerk, Sofia F. Garcia, Karen L. Smith, Della Makower, Margaret Block, Kimberly Morley, Chirag Jani, Craig Mescher, Shabana J. Dewani, Bernard Tawfik, Lisa Flaum, Erica L. Mayer, William M. Sikov, Eve T. Rodler, Lynne I. Wagner, Angela DeMichele, Joseph A. Sparano, Antonio C. Wolff, Kathy D. Miller - Journal of Clinical Oncology 2021 cited by 136

  19. Plasma Membrane Channel TRPM4 Mediates Immunogenic Therapy–Induced Necrosis

    Authors: Santanu Ghosh, Rachel Yang, Darjan Duraki, Junyao Zhu, Ji Eun Kim, Musarrat Jabeen, Chengjian Mao, Xinyi Dai, Mara R. Livezey, Matthew W. Boudreau, Ben Ho Park, Erik R. Nelson, Paul J. Hergenrother, David J. Shapiro - Cancer Research 2023 cited by 29

  20. Circulating Tumor DNA: Measurement and Clinical Utility

    Authors: Joshua Donaldson, Ben Ho Park - Annual Review of Medicine 2017 cited by 98

  21. Prediction of Effectiveness and Toxicities of Immune Checkpoint Inhibitors Using Real-World Patient Data

    Authors: Levente Lippenszky, Kathleen F. Mittendorf, Zoltán Kiss, Michele L. Lenoue-Newton, Pablo Napan-Molina, Protiva Rahman, Cheng Ye, Balázs Laczi, Eszter Csernai, Neha Jain, Marilyn Holt, C. Noel Maxwell, Madeleine Ball, Yufang Ma, Margaret B. Mitchell, Douglas B. Johnson, David S. Smith, Ben Ho Park, Christine Micheel, Daniel Fabbri, Jan Wolber, Travis Osterman - JCO Clinical Cancer Informatics 2024 cited by 24

  22. Characteristics and Outcome of AKT1 E17K-Mutant Breast Cancer Defined through AACR Project GENIE, a Clinicogenomic Registry

    Authors: Lillian M. Smyth, Qin Zhou, Bastien Nguyen, Celeste Yu, Eva M. Lepisto, Mónica Arnedos, Michael J. Hasset, Michele L. Lenoue-Newton, Natalie Blauvelt, Semih Doğan, Christine Micheel, Chetna Wathoo, Hugo M. Horlings, Jan Hudeček, Benjamin Groß, Ritika Kundra, Shawn M. Sweeney, Jianjiong Gao, Nikolaus Schultz, Andrew Zarski, Stuart M. Gardos, Jocelyn Lee, Seth Sheffler‐Collins, Ben Ho Park, Charles L. Sawyers, Fabrice André, Mia Levy, Funda Meric‐Bernstam, Philippe L. Bédard, Alexia Iasonos, Deborah Schrag, David M. Hyman - Cancer Discovery 2020 cited by 51

  23. HER2 Reactivation through Acquisition of the HER2 L755S Mutation as a Mechanism of Acquired Resistance to HER2-targeted Therapy in HER2+ Breast Cancer

    Authors: Xiaowei Xu, Carmine De Angelis, Kathleen A. Burke, Agostina Nardone, Huizhong Hu, Lanfang Qin, Jamunarani Veeraraghavan, Vidyalakshmi Sethunath, Laura M. Heiser, Nicholas Wang, Charlotte K.Y. Ng, Edward S. Chen, Alexander Renwick, Tao Wang, Sarmistha Nanda, Martin J. Shea, Tamika Mitchell, Mahitha Rajendran, Ian Waters, Daniel J. Zabransky, Kenneth L. Scott, Carolina Gutiérrez, Chandandeep Nagi, Felipe C. Geyer, Gary C. Chamness, Ben Ho Park, Chad A. Shaw, Susan G. Hilsenbeck, Mothaffar F. Rimawi, Joe W. Gray, Britta Weigelt, Jorge S. Reis‐Filho, C. Kent Osborne, Rachel Schiff - Clinical Cancer Research 2017 cited by 129

  24. Ki-67 is required for maintenance of cancer stem cells but not cell proliferation

    Authors: Justin Cidado, Hong Yuen Wong, David Rosen, Ashley Cimino‐Mathews, Joseph P. Garay, Abigail G. Fessler, Zeshaan A. Rasheed, Jessica Hicks, Rory L. Cochran, Sarah Croessmann, Daniel J. Zabransky, Morassa Mohseni, Julia A. Beaver, David Chu, Karen Cravero, Eric S. Christenson, Arielle J. Medford, Austin K. Mattox, Angelo M. De Marzo, Pedram Argani, Ajay Chawla, Paula J. Hurley, Josh Lauring, Ben Ho Park - Oncotarget 2016 cited by 114